Advanced Oncotherapy (AVO) Insider Trading & Ownership → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free AVO Stock Alerts GBX 1.75 -0.18 (-9.09%) (As of 08/30/2023) Add Compare Share Share Insider TradesStock AnalysisInsider TradesStock AnalysisInsider Trades Advanced Oncotherapy (LON:AVO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage47.53%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)£46,000.00Number OfInsiders Selling(Last 3 Years)0 Get AVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Advanced Oncotherapy stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVO Insider Buying and Selling by Quarter Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Advanced Oncotherapy Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/28/2022Enrico Cipro VanniInsiderBuy80,000GBX 13£10,40012/23/2022Michael J SinclairInsiderBuy80,000GBX 12£9,6003/2/2022Enrico Cipro VanniInsiderBuy100,000GBX 26£26,000 (Data available from 1/1/2013 forward) AVO Insider Trading Activity - Frequently Asked Questions Who is on Advanced Oncotherapy's Insider Roster? The list of insiders at Advanced Oncotherapy includes Enrico Cipro Vanni, and Michael J Sinclair. Learn more on insiders at AVO. What percentage of Advanced Oncotherapy stock is owned by insiders? 47.53% of Advanced Oncotherapy stock is owned by insiders. Learn more on AVO's insider holdings. Which Advanced Oncotherapy insiders have been buying company stock? The following insiders have purchased AVO shares in the last 24 months: Enrico Cipro Vanni (£10,400), and Michael J Sinclair (£9,600). How much insider buying is happening at Advanced Oncotherapy? Insiders have purchased a total of 160,000 AVO shares in the last 24 months for a total of £20,000 bought. More Insider Trading Tools from MarketBeat Related Companies: IHC Insider Trades BVX Insider Trades TLY Insider Trades INHC Insider Trades SAR Insider Trades ABDX Insider Trades ROQ Insider Trades ODX Insider Trades OCTP Insider Trades FAB Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (LON:AVO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Advanced Oncotherapy plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
